David E. Spaner, Guizhei Wang, Lindsay McCaw, Yanmei Li, Patricia Disperati, Mary-Ann Cussen, and Yonghong Shi. 2016. “Activity of the Janus Kinase Inhibitor Ruxolitinib in Chronic Lymphocytic Leukemia: Results of a Phase II Trial”. Haematologica 101 (5). Pavia, Italy, e192-e195. https://doi.org/10.3324/haematol.2015.135418.